Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Response and side effects

From: Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

ID response grade III/IV side effects
hematologic non-hematologic
1 PR no no
2 PR pancytopenia no
3 CR leukopenia no
4 CR no no
5 CR pancytopenia no
6 CR no no
7 SD no no
8 CR leukopenia no
9 PD no no
10 PR no no
11 PD no no
  1. PR partial response, CR complete response, SD stable disease, PD progressive disease